Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence

S Spudich, J Peterson, D Fuchs, RW Price, M Gisslen - Aids, 2019 - journals.lww.com
Although treatment with antiretroviral therapy (ART) improves central nervous inflammation,
limits viral replication detected in the cerebrospinal fluid, and prevents severe clinical …
被引用次数：22 相关文章

Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence.

S Spudich, J Peterson, D Fuchs, RW Price… - AIDS (London …, 2019 - europepmc.org
: Although treatment with antiretroviral therapy (ART) improves central nervous inflammation,
limits viral replication detected in the cerebrospinal fluid, and prevents severe clinical …

Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence

S Spudich, J Peterson, D Fuchs… - AIDS (London …, 2019 - pubmed.ncbi.nlm.nih.gov
: Although treatment with antiretroviral therapy (ART) improves central nervous inflammation,
limits viral replication detected in the cerebrospinal fluid, and prevents severe clinical …

Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence.

S Spudich, J Peterson, D Fuchs, RW Price, M Gisslen - 2019 - cabidigitallibrary.org
Although treatment with antiretroviral therapy (ART) improves central nervous inflammation,
limits viral replication detected in the cerebrospinal fluid, and prevents severe clinical …